ESPE Abstracts (2019) 92 P2-287

ESPE2019 Poster Category 2 Thyroid (26 abstracts)

Bone Homeostasis in Children with Subclinical Hypothyroidism: Effects of Two-years Treatment with Levothyoxine

Flavia Barbieri 1 , Andrea Esposito 1 , Ida D'Acunzo 1 , Paola Lorello 1 , Raffaella Di Mase 2 , Nicola Improda 1 & Donatella Capalbo 2


1Department of Translational Medical Sciences, University Federico II, Naples, Italy. 2Pediatric Endocrine Unit, Department of Translational Medical Sciences, University Federico II, Naples, Italy

Background: Thyroid hormone plays a key role in bone mineral homeostasis and significant alterations in its circulating levels have been associated with an impairment in skeletal growth during childhood. To date, the effects of subclinical hypothyroidism (SH) on bones have not been studied and the management of this condition is still debated.

Aim: To evaluate bone mineral density (BMD) in children with mild, persistent SH and the effects of two -years treatment with levothyroxine (L-T4) on skeletal homeostasis.

Methods: Seventeen children (8 males), aged 8.7±1.03 years with mild (TSH levels between 4.2 and 10 mU/l), persistent (≥2 years from the diagnosis) and idiopathic SH were enrolled in the study, and compared to 17 age-, sex- and BMI- matched controls. At study entry, both groups underwent clinical examination, laboratory evaluation and dual-energy X-ray densitometry (DXA) scan to evaluate the lumbar spine BMD. Moreover, SH children received 2-year L-T4 treatment and were then reassessed to evaluate possible changes in bone mineral status.

Results: At study entry, mean BMD Z-score was normal in SH subjects and comparable to healthy controls (-0.41±0.42 vs -0.12±0.25, respectively, p ns). After two years of L-T4 therapy, a mild, but not significant, increase in BMD z-score was observed in SH children, compared to baseline values (0.81±0.56, P=0.08).

Conclusions: Despite long-term duration, idiopathic SH in children is not associated with impaired BMD, evaluated by lumbar spine DXA. Two-years of L-T4 treatment do not seem to significantly improve BMD in children with SH.

Volume 92

58th Annual ESPE

Vienna, Austria
19 Sep 2019 - 21 Sep 2019

European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.